Westfield Capital Management CO LP Xenon Pharmaceuticals Inc. Transaction History
Westfield Capital Management CO LP
- $19.3 Billion
- Q1 2025
A detailed history of Westfield Capital Management CO LP transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 1,391,370 shares of XENE stock, worth $50.1 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,391,370
Previous 1,157,189
20.24%
Holding current value
$50.1 Million
Previous $45.4 Million
2.91%
% of portfolio
0.24%
Previous 0.21%
Shares
6 transactions
Others Institutions Holding XENE
# of Institutions
220Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$194 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$156 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$130 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$129 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$115 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.24B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...